$STI

Solidion Technology (STI) gives director 3-year stock grant

Solidion Technology (STI) granted director Robinson Dante W 4,296 restricted stock units (RSUs) at $0.00 per share. The RSUs will vest in three equal installments from 2027 to 2029, subject to continuous service. Early vesting may occur in case of a corporate transaction. The grant was made under the company’s 2023 Equity Incentive Plan.

Original reporting
Published Sep 3, 2026, 10:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 3, 2026, 11:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$STI
Neutral
high confidence
Mentioned
$STI
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$STINeutralLow
01

Why it matters

The award is routine compensation with no immediate financial impact; investors may monitor future vesting or corporate transaction triggers.

02

Market read

Low relevance; typical insider grant with negligible market effect.

03

What to watch

Potential acceleration clause if a corporate transaction occurs could increase dilution risk.

Relevance 4/10Novelty 3/10Timing: post-filing September 3, 2026

Background

Solidion Technology filed a Form 4 reporting a director's RSU award under its 2023 Equity Incentive Plan.

Company-level read

Ticker impact

$STINeutralHigh confidence
Context

Form 4 filing shows director Robinson Dante W received a grant of 4,296 RSUs at $0, vesting over three years.

Expected impact

Minimal impact; price likely unchanged.

Evidence & confidence

The grant is modest in size and at zero price, typical routine compensation with no dilution risk until vesting.

Market effects

None; compensation grant does not affect sector dynamics.

None; company is small and US‑focused.

None; limited to the issuer.

Counterpoint

If the director's future role expands, the RSU grant could signal upcoming strategic moves.

Key entities

  • Solidion Technology Inc.

    Issuer of the RSU grant.

  • Robinson Dante W

    Director receiving the RSU award.

Related articles

$STIMed

Solidion Technology Inc. (STI): Results of Operations and Financial Condition

Solidion Technology Inc. (STI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Private Placement Eliminates Balance Sheet Overhang and Alleviates Previously Disclosed Going Concern Doubt DALLAS, Aug. 6, 2026 /PRNewswire/ -- Solidion Technology Inc. (“Solidion” or the “Company”) (Nasdaq: STI), an advanced battery technology solutions provider, t

$STIMed

Solidion Technology, Inc.: Solidion Technology Achieves Dramatic Balance Sheet Improvement, Increased Revenues

Solidion Technology (Nasdaq: STI) reported Q2 2026 results, citing a $35 million private placement that it says eliminated going-concern doubt. Cash rose to $27.7 million at June 30, 2026 from $0.2 million at Dec. 31, 2025. Revenue was $124,914 from government grants and product deliveries. Net loss was $2.9 million ($0.35/share).

$STIMedAI 8/10

Solidion Technology Announces Closing of $35 Million Private Placement of Common Stock Priced Above Market Under Nasdaq Rules

Solidion Technology (NASDAQ: STI) said it closed a $35 million private placement of 2,333,000 shares of common stock priced above market under Nasdaq rules. The company will use net proceeds to fund commercialization of its Extreme-Climate Battery technology, meet customer demand, expand inventory, advance prototypes, and for working capital. Titan Partners acted as sole placement agent.

$STIMedAI 8/10

Benzinga

Solidion Technology (NASDAQ:STI) said it received seven new U.S. patents covering its silicon anode materials, bringing its U.S. anode-material patent portfolio to 130. The company said its silane-free, porous graphene ball process can hold up to 90% silicon and targets safety, cost, and supply issues. The patent update follows a $35 million private placement; Solidion plans to sell 2,333,000 shares priced above market under Nasdaq rules, with proceeds funding operations through 2028.

$STIMedAI 8/10

Solidion Technology Announces $35 Million Private Placement of Common Stock Priced Above Market Under Nasdaq Rules

Solidion Technology (NASDAQ: STI) said it will sell 2,333,000 shares of common stock (or equivalents) in a private placement to a new institutional investor at a price above market under Nasdaq rules. Gross proceeds are expected to total $35 million, with closing on or about June 9, 2026. The company plans to use net proceeds to fund commercialization, prototypes, customer demand, inventory, and working capital.